| 22.95 Delayed Data As of Nov 15 |  +0.42 / +1.86%Today’s Change | 16.03 Today|||52-Week Range 36.15 | +25.31% Year-to-Date |
| Quanterix Corporation (QTRX) Q3 2019 Earnings Call Transcript Nov 07 / MotleyFool.com - Paid Partner Content |
| Previous close | 22.53 |
| Today’s open | 22.75 |
| Day’s range | 22.32 - 23.16 |
| Volume | 99,721 |
| Average volume (3 months) | 203,567 |
| Market cap | $644.1M |
| Earnings growth (last year) | +82.73% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +4.00% |
| Revenue growth (last year) | +64.52% |
| P/E ratio | NM |
| Price/Sales | 10.70 |
| Price/Book | 12.52 |
| Today’s change | Today’s % change | |
|---|---|---|
| SVASinovac Biotech Ltd | 0.00 | 0.00% |
| OMEROmeros Corp | -0.61 | -4.42% |
| KURAKura Oncology Inc | -0.17 | -1.14% |
| FLXNFlexion Therapeutics... | +0.11 | +0.69% |
| Next reporting date | March 11, 2020 |
| EPS forecast (this quarter) | -$0.43 |
| Annual revenue (last year) | $37.6M |
| Annual profit (last year) | -$31.5M |
| Net profit margin | -83.80% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Billerica, Massachusetts |
